Environmental arginine controls multinuclear giant cell metabolism and formation.


Journal

Nature communications
ISSN: 2041-1723
Titre abrégé: Nat Commun
Pays: England
ID NLM: 101528555

Informations de publication

Date de publication:
22 01 2020
Historique:
received: 22 03 2019
accepted: 16 12 2019
entrez: 24 1 2020
pubmed: 24 1 2020
medline: 14 4 2020
Statut: epublish

Résumé

Multinucleated giant cells (MGCs) are implicated in many diseases including schistosomiasis, sarcoidosis and arthritis. MGC generation is energy intensive to enforce membrane fusion and cytoplasmic expansion. Using receptor activator of nuclear factor kappa-Β ligand (RANKL) induced osteoclastogenesis to model MGC formation, here we report RANKL cellular programming requires extracellular arginine. Systemic arginine restriction improves outcome in multiple murine arthritis models and its removal induces preosteoclast metabolic quiescence, associated with impaired tricarboxylic acid (TCA) cycle function and metabolite induction. Effects of arginine deprivation on osteoclastogenesis are independent of mTORC1 activity or global transcriptional and translational inhibition. Arginine scarcity also dampens generation of IL-4 induced MGCs. Strikingly, in extracellular arginine absence, both cell types display flexibility as their formation can be restored with select arginine precursors. These data establish how environmental amino acids control the metabolic fate of polykaryons and suggest metabolic ways to manipulate MGC-associated pathologies and bone remodelling.

Identifiants

pubmed: 31969567
doi: 10.1038/s41467-020-14285-1
pii: 10.1038/s41467-020-14285-1
pmc: PMC6976629
doi:

Substances chimiques

RANK Ligand 0
Interleukin-4 207137-56-2
Arginine 94ZLA3W45F
Mechanistic Target of Rapamycin Complex 1 EC 2.7.11.1

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

431

Subventions

Organisme : Austrian Science Fund FWF
ID : P 30026
Pays : Austria

Commentaires et corrections

Type : CommentIn

Références

McInnes, I. B. & Schett, G. The pathogenesis of rheumatoid arthritis. N. Engl. J. Med. 365, 2205–2219 (2011).
pubmed: 22150039 doi: 10.1056/NEJMra1004965
Kong, Y. Y. et al. OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397, 315–323 (1999).
pubmed: 9950424 doi: 10.1038/16852
Lavin, Y. et al. Tissue-resident macrophage enhancer landscapes are shaped by the local microenvironment. Cell 159, 1312–1326 (2014).
pubmed: 25480296 pmcid: 25480296 doi: 10.1016/j.cell.2014.11.018
O’Neill, L. A. & Pearce, E. J. Immunometabolism governs dendritic cell and macrophage function. J. Exp. Med. 213, 15–23 (2016).
pubmed: 26694970 pmcid: 4710204 doi: 10.1084/jem.20151570
Geiger, R. et al. L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity. Cell 167, 829–842.e813 (2016).
pubmed: 27745970 pmcid: 5075284 doi: 10.1016/j.cell.2016.09.031
Murray, P. J. Amino acid auxotrophy as a system of immunological control nodes. Nat. Immunol. 17, 132 (2016).
pubmed: 26784254 pmcid: 4893777 doi: 10.1038/ni.3323
Caputa, G., Castoldi, A. & Pearce, E. J. Metabolic adaptations of tissue-resident immune cells. Nat. Immunol. 20, 793–801 (2019).
pubmed: 31213715 doi: 10.1038/s41590-019-0407-0 pmcid: 31213715
Vincent, E. E. et al. Mitochondrial phosphoenolpyruvate carboxykinase regulates metabolic adaptation and enables glucose-independent tumor growth. Mol. Cell 60, 195–207 (2015).
pubmed: 26474064 doi: 10.1016/j.molcel.2015.08.013 pmcid: 26474064
Ali, U. et al. L-asparaginase as a critical component to combat Acute Lymphoblastic Leukaemia (ALL): a novel approach to target ALL. Eur. J. Pharmacol. 771, 199–210 (2016).
pubmed: 26698391 doi: 10.1016/j.ejphar.2015.12.023 pmcid: 26698391
Yau, T. et al. Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma. Invest. New Drugs 33, 496–504 (2015).
pubmed: 25666409 doi: 10.1007/s10637-014-0200-8 pmcid: 25666409
Qiu, F., Huang, J. & Sui, M. Targeting arginine metabolism pathway to treat arginine-dependent cancers. Cancer Lett. 364, 1–7 (2015).
pubmed: 25917076 doi: 10.1016/j.canlet.2015.04.020 pmcid: 25917076
Ditzel, H. J. The K/BxN mouse: a model of human inflammatory arthritis. Trends Mol. Med. 10, 40–45 (2004).
pubmed: 14720585 doi: 10.1016/j.molmed.2003.11.004 pmcid: 14720585
Keffer, J. et al. Transgenic mice expressing human tumour necrosis factor: a predictive genetic model of arthritis. EMBO J. 10, 4025–4031 (1991).
pubmed: 1721867 pmcid: 453150 doi: 10.1002/j.1460-2075.1991.tb04978.x
Courtenay, J. S., Dallman, M. J., Dayan, A. D., Martin, A. & Mosedale, B. Immunisation against heterologous type II collagen induces arthritis in mice. Nature 283, 666–668 (1980).
pubmed: 6153460 doi: 10.1038/283666a0 pmcid: 6153460
Morris, S. M. Jr. Arginine metabolism: boundaries of our knowledge. J. Nutr. 137, 1602s–1609s (2007).
pubmed: 17513435 doi: 10.1093/jn/137.6.1602S pmcid: 17513435
Maruyama, K. et al. The transcription factor Jdp2 controls bone homeostasis and antibacterial immunity by regulating osteoclast and neutrophil differentiation. Immunity 37, 1024–1036 (2012).
pubmed: 23200825 doi: 10.1016/j.immuni.2012.08.022 pmcid: 23200825
El Kasmi, K. C. et al. Toll-like receptor-induced arginase 1 in macrophages thwarts effective immunity against intracellular pathogens. Nat. Immunol. 9, 1399–1406 (2008).
pubmed: 18978793 pmcid: 2584974 doi: 10.1038/ni.1671
Wang, S. et al. The amino acid transporter SLC38A9 is a key component of a lysosomal membrane complex that signals arginine sufficiency to mTORC1. Science 347, 188–194 (2015).
pubmed: 25567906 pmcid: 4295826 doi: 10.1126/science.1257132
Weichhart, T., Hengstschläger, M. & Linke, M. Regulation of innate immune cell function by mTOR. Nat. Rev. Immunol. 15, 599–614 (2015).
pubmed: 26403194 pmcid: 6095456 doi: 10.1038/nri3901
Rebsamen, M. et al. SLC38A9 is a component of the lysosomal amino acid sensing machinery that controls mTORC1. Nature 519, 477–481 (2015).
pubmed: 25561175 pmcid: 4376665 doi: 10.1038/nature14107
Pakos-Zebrucka, K. et al. The integrated stress response. EMBO Rep. 17, 1374–1395 (2016).
pubmed: 27629041 pmcid: 5048378 doi: 10.15252/embr.201642195
Zeng, R., Faccio, R. & Novack, D. V. Alternative NF-kappaB regulates RANKL-induced osteoclast differentiation and mitochondrial biogenesis via independent mechanisms. J. Bone Miner. Res. 30, 2287–2299 (2015).
pubmed: 26094846 pmcid: 4834842 doi: 10.1002/jbmr.2584
Ishii, K. A. et al. Coordination of PGC-1beta and iron uptake in mitochondrial biogenesis and osteoclast activation. Nat. Med. 15, 259–266 (2009).
pubmed: 19252502 doi: 10.1038/nm.1910 pmcid: 19252502
Jha, A. K. et al. Network integration of parallel metabolic and transcriptional data reveals metabolic modules that regulate macrophage polarization. Immunity 42, 419–430 (2015).
pubmed: 25786174 doi: 10.1016/j.immuni.2015.02.005 pmcid: 25786174
Shambaugh, G. E. 3rd Urea biosynthesis I. The urea cycle and relationships to the citric acid cycle. Am. J. Clin. Nutr. 30, 2083–2087 (1977).
pubmed: 337792 doi: 10.1093/ajcn/30.12.2083 pmcid: 337792
Broer, S. & Broer, A. Amino acid homeostasis and signalling in mammalian cells and organisms. Biochem. J. 474, 1935–1963 (2017).
pubmed: 28546457 pmcid: 5444488 doi: 10.1042/BCJ20160822
Qualls, J. E. et al. Sustained generation of nitric oxide and control of mycobacterial infection requires argininosuccinate synthase 1. Cell Host Microbe 12, 313–323 (2012).
pubmed: 22980328 pmcid: 3444824 doi: 10.1016/j.chom.2012.07.012
Yeon, J. T. et al. Natural polyamines inhibit the migration of preosteoclasts by attenuating Ca2+-PYK2-Src-NFATc1 signaling pathways. Amino Acids 46, 2605–2614 (2014).
pubmed: 25216923 doi: 10.1007/s00726-014-1797-9 pmcid: 25216923
Metcalf, B. W. et al. Catalytic irreversible inhibition of mammalian ornithine decarboxylase (E C 4 1 1 17) by substrate and product analogs. J. Am. Chem. Soc. 100, 2551–2553 (1978).
doi: 10.1021/ja00476a050
Fletcher, M. et al. l-Arginine depletion blunts antitumor T-cell responses by inducing myeloid-derived suppressor cells. Cancer Res. 75, 275–283 (2014).
pubmed: 25406192 pmcid: 4297565 doi: 10.1158/0008-5472.CAN-14-1491
Chen, C. et al. TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species. J. Exp. Med. 205, 2397–2408 (2008).
pubmed: 18809716 pmcid: 2556783 doi: 10.1084/jem.20081297
Buck, M. D., Sowell, R. T., Kaech, S. M. & Pearce, E. L. Metabolic Instruction of Immunity. Cell 169, 570–586 (2017).
pubmed: 28475890 pmcid: 5648021 doi: 10.1016/j.cell.2017.04.004
Manoli, I. & Venditti, C. P. Disorders of branched chain amino acid metabolism. Transl. Sci. Rare Dis. 1, 91–110 (2016).
pubmed: 29152456 pmcid: 5685199
Milde, R. et al. Multinucleated giant cells are specialized for complement-mediated phagocytosis and large target destruction. Cell Rep. 13, 1937–1948 (2015).
pubmed: 26628365 pmcid: 4675895 doi: 10.1016/j.celrep.2015.10.065
Pereira, M. et al. Common signalling pathways in macrophage and osteoclast multinucleation. J. Cell Sci. 131, jcs216267 (2018).
pubmed: 29871956 doi: 10.1242/jcs.216267 pmcid: 29871956
Yeon, J. T., Choi, S. W. & Kim, S. H. Arginase 1 is a negative regulator of osteoclast differentiation. Amino Acids 48, 559–565 (2016).
pubmed: 26475291 doi: 10.1007/s00726-015-2112-0 pmcid: 26475291
Cejka, D. et al. Mammalian target of rapamycin signaling is crucial for joint destruction in experimental arthritis and is activated in osteoclasts from patients with rheumatoid arthritis. Arthritis Rheumatol. 62, 2294–2302 (2010).
doi: 10.1002/art.27504
Huynh, H. & Wan, Y. mTORC1 impedes osteoclast differentiation via calcineurin and NFATc1. Commun. Biol. 1, 29 (2018).
pubmed: 30271915 pmcid: 6123628 doi: 10.1038/s42003-018-0028-4
Salahudeen, A. A. et al. An E3 ligase possessing an iron-responsive hemerythrin domain is a regulator of iron homeostasis. Science 326, 722–726 (2009).
pubmed: 19762597 pmcid: 3582197 doi: 10.1126/science.1176326
Lendahl, U., Lee, K. L., Yang, H. & Poellinger, L. Generating specificity and diversity in the transcriptional response to hypoxia. Nat. Rev. Genet. 10, 821–832 (2009).
pubmed: 19884889 doi: 10.1038/nrg2665 pmcid: 19884889
Haslacher, H et al. Usage Data and Scientific Impact of the Prospectively Established Fluid Bioresources at the Hospital-Based MedUni Wien Biobank. Biopreservation and biobanking 16, 477–482 (2018).
pmcid: 6308288 doi: 10.1089/bio.2018.0032
Bluml, S. et al. Essential role of microRNA-155 in the pathogenesis of autoimmune arthritis in mice. Arthritis Rheumatol. 63, 1281–1288 (2011).
doi: 10.1002/art.30281
Bluml, S. et al. Loss of phosphatase and tensin homolog (PTEN) in myeloid cells controls inflammatory bone destruction by regulating the osteoclastogenic potential of myeloid cells. Ann. Rheum. Dis. 74, 227–233 (2015).
pubmed: 24078675 doi: 10.1136/annrheumdis-2013-203486 pmcid: 24078675
Van de Velde, L. A. et al. Stress kinase GCN2 controls the proliferative fitness and trafficking of cytotoxic T cells independent of environmental amino acid sensing. Cell Rep. 17, 2247–2258 (2016).
pubmed: 27880901 pmcid: 5131879 doi: 10.1016/j.celrep.2016.10.079
Copp, J., Manning, G. & Hunter, T. TORC-specific phosphorylation of mTOR: phospho-Ser2481 is a marker for intact mTORC2. Cancer Res. 69, 1821–1827 (2009).
pubmed: 19244117 pmcid: 2652681 doi: 10.1158/0008-5472.CAN-08-3014
Linke, M. et al. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression. Nat. Immunol. 18, 293–302 (2017).
pubmed: 28092373 pmcid: 5321578 doi: 10.1038/ni.3655
Carpenter, A. E. et al. CellProfiler: image analysis software for identifying and quantifying cell phenotypes. Genome Biol. 7, R100 (2006).
pubmed: 17076895 pmcid: 1794559 doi: 10.1186/gb-2006-7-10-r100
Galili, T., O’Callaghan, A., Sidi, J. & Sievert, C. heatmaply: an R package for creating interactive cluster heatmaps for online publishing. Bioinformatics 34, 1600–1602 (2018).
pubmed: 29069305 doi: 10.1093/bioinformatics/btx657 pmcid: 29069305
Tuncbag, N. et al. Network-based interpretation of diverse high-throughput datasets through the omics integrator software package. PLoS Comput. Biol. 12, e1004879 (2016).
pubmed: 27096930 pmcid: 4838263 doi: 10.1371/journal.pcbi.1004879
Rosvall, M. & Bergstrom, C. T. Multilevel compression of random walks on networks reveals hierarchical organization in large integrated systems. PLoS ONE 6, e18209 (2011).
pubmed: 21494658 pmcid: 3072965 doi: 10.1371/journal.pone.0018209
Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Res. 13, 2498–2504 (2003).
pubmed: 14597658 pmcid: 403769 doi: 10.1101/gr.1239303
Kim, D. et al. TopHat2: accurate alignment of transcriptomes in the presence of insertions, deletions and gene fusions. Genome Biol. 14, R36 (2013).
pubmed: 23618408 pmcid: 23618408 doi: 10.1186/gb-2013-14-4-r36
Liao, Y., Smyth, G. K. & Shi, W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 41, e108 (2013).
pubmed: 23558742 pmcid: 3664803 doi: 10.1093/nar/gkt214
Law, C. W., Chen, Y., Shi, W. & Smyth, G. K. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 15, R29 (2014).
pubmed: 24485249 pmcid: 4053721 doi: 10.1186/gb-2014-15-2-r29
Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).
pubmed: 25605792 pmcid: 25605792 doi: 10.1093/nar/gkv007
Robinson, M. D., McCarthy, D. J. & Smyth, G. K. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics 26, 139–140 (2010).
doi: 10.1093/bioinformatics/btp616 pubmed: 19910308
Yu, G., Wang, L. G., Han, Y. & He, Q. Y. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284–287 (2012).
pubmed: 22455463 pmcid: 3339379 doi: 10.1089/omi.2011.0118
Ashburner, M. et al. Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25, 25–29 (2000).
pubmed: 10802651 pmcid: 3037419 doi: 10.1038/75556
Consortium, T. G. O. Expansion of the Gene Ontology knowledgebase and resources. Nucleic Acids Res. 45, D331–D338 (2017).
Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27–30 (2000).
pubmed: 10592173 pmcid: 10592173 doi: 10.1093/nar/28.1.27
Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. & Morishima, K. KEGG: new perspectives on genomes, pathways, diseases and drugs. Nucleic Acids Res. 45, D353–D361 (2017).
Kelstrup, C. D. et al. Performance evaluation of the Q exactive HF-X for shotgun proteomics. J. Proteome Res. 17, 727–738 (2018).
pubmed: 29183128 doi: 10.1021/acs.jproteome.7b00602 pmcid: 29183128
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372 (2008).
pubmed: 19029910 pmcid: 19029910 doi: 10.1038/nbt.1511
Cox, J. et al. Andromeda: a peptide search engine integrated into the MaxQuant environment. J. Proteome Res. 10, 1794–1805 (2011).
pubmed: 21254760 doi: 10.1021/pr101065j pmcid: 21254760
Tyanova, S. et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat. Methods 13, 731–740 (2016).
pubmed: 27348712 doi: 10.1038/nmeth.3901 pmcid: 27348712
Chatr-Aryamontri, A. et al. The BioGRID interaction database: 2017 update. Nucleic Acids Res. 45, D369–D379 (2017).
pubmed: 27980099 pmcid: 5210573 doi: 10.1093/nar/gkw1102
Bohlin L., Edler D., Lancichinetti A., Rosvall M. Community Detection and Visualization of Networks with the Map Equation Framework. In: Ding Y., Rousseau R., Wolfram D. (eds) Measuring Scholarly Impact. Springer, Cham 3–34 (2014)
Vizcaino, J. A. et al. 2016 update of the PRIDE database and its related tools. Nucleic Acids Res. 44, 11033 (2016).
pubmed: 27683222 pmcid: 5159556 doi: 10.1093/nar/gkw880

Auteurs

Julia S Brunner (JS)

Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, 1090, Vienna, Austria.
Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, 1090, Vienna, Austria.

Loan Vulliard (L)

CeMM Research Centre for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.

Melanie Hofmann (M)

Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, 1090, Vienna, Austria.
Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, 1090, Vienna, Austria.

Markus Kieler (M)

Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, 1090, Vienna, Austria.
Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, 1090, Vienna, Austria.

Alexander Lercher (A)

CeMM Research Centre for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.

Andrea Vogel (A)

Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, 1090, Vienna, Austria.
Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, 1090, Vienna, Austria.

Marion Russier (M)

Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.

Johanna B Brüggenthies (JB)

Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.

Martina Kerndl (M)

Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, 1090, Vienna, Austria.
Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, 1090, Vienna, Austria.

Victoria Saferding (V)

Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, 1090, Vienna, Austria.

Birgit Niederreiter (B)

Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, 1090, Vienna, Austria.

Alexandra Junza (A)

CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029, Madrid, Spain.
Metabolomics Platform, IISPV, Department of Electronic Engineering, Universitat Rovira i Virgili, 43204, Tarragona, Spain.

Annika Frauenstein (A)

Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.

Carina Scholtysek (C)

Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, 91054, Erlangen, Germany.

Yohei Mikami (Y)

Molecular Immunology and Inflammation Branch, NIAMS, National Institutes of Health, Bethesda, MD, Bethesda, MD, 20892, USA.
Division of Gastroenterology and Hepatology, Department of Internal Medicine, Keio University School of Medicine, Shinanomachi, Shinjuku-ku, Tokyo, 160-8582, Japan.

Kristaps Klavins (K)

CeMM Research Centre for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.

Gerhard Krönke (G)

Department of Internal Medicine 3, Rheumatology and Immunology, Friedrich-Alexander-University Erlangen-Nürnberg (FAU) and Universitätsklinikum Erlangen, 91054, Erlangen, Germany.

Andreas Bergthaler (A)

CeMM Research Centre for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.

John J O'Shea (JJ)

Molecular Immunology and Inflammation Branch, NIAMS, National Institutes of Health, Bethesda, MD, Bethesda, MD, 20892, USA.

Thomas Weichhart (T)

Center of Pathobiochemistry and Genetics, Institute of Medical Genetics, Medical University of Vienna, 1090, Vienna, Austria.

Felix Meissner (F)

Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.

Josef S Smolen (JS)

Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, 1090, Vienna, Austria.

Paul Cheng (P)

Bio Cancer Treatment International Ltd., 999077, Hong Kong, China.

Oscar Yanes (O)

CIBER of Diabetes and Associated Metabolic Diseases (CIBERDEM), 28029, Madrid, Spain.
Metabolomics Platform, IISPV, Department of Electronic Engineering, Universitat Rovira i Virgili, 43204, Tarragona, Spain.

Jörg Menche (J)

CeMM Research Centre for Molecular Medicine of the Austrian Academy of Sciences, 1090, Vienna, Austria.

Peter J Murray (PJ)

Max Planck Institute of Biochemistry, 82152, Martinsried, Germany.

Omar Sharif (O)

Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, 1090, Vienna, Austria.
Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, 1090, Vienna, Austria.

Stephan Blüml (S)

Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, 1090, Vienna, Austria. stephan.blueml@meduniwien.ac.at.
Division of Rheumatology, Department of Internal Medicine III, Medical University of Vienna, 1090, Vienna, Austria. stephan.blueml@meduniwien.ac.at.

Gernot Schabbauer (G)

Institute for Vascular Biology, Centre for Physiology and Pharmacology, Medical University Vienna, 1090, Vienna, Austria. gernot.schabbauer@meduniwien.ac.at.
Christian Doppler Laboratory for Arginine Metabolism in Rheumatoid Arthritis and Multiple Sclerosis, 1090, Vienna, Austria. gernot.schabbauer@meduniwien.ac.at.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH